Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (9): 1443-1447.doi: 10.16352/j.issn.1001-6325.2023.09.1443
• Mini Reviews • Previous Articles Next Articles
SONG Xingming, Harisa·ERKENJIAN, Dilihumal·ABLAITI, GAO Ying*
Received:
2022-08-29
Revised:
2023-02-22
Online:
2023-09-05
Published:
2023-09-01
Contact:
*sunflowergaoying@163.com
CLC Number:
SONG Xingming, Harisa·ERKENJIAN, Dilihumal·ABLAITI, GAO Ying. Research progress of endothelial lipase as a therapeutic target for coronary heart disease[J]. Basic & Clinical Medicine, 2023, 43(9): 1443-1447.
[1] | Jaye M,Lynch KJ,Krawiec J, et al.A novel endothelial-derived lipase that modulates HDL metabolism[J].Nat Genet,1999,2:424-428. |
[2] | Liu C,Dhindsa D,Almuwaqqat Z, et al.Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations[J].JAMA Cardiol,2022,7:672-680. |
[3] | Yang S,Yin RX,Miao L, et al.LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels[J].Lipids Health Dis,2019,18:10.doi:10.1186/s12944-018-0942-y. |
[4] | Nagao M,Miyashita K,Mori K, et al.Serum concentration of full-length-and carboxy-terminal fragments of endothelial lipase predicts future cardiovascular risks in patients with coronary artery disease[J].J Clin Lipidol,2019,13:839-846. |
[5] | 其布热,周红,董莉.内皮酯酶基因多态性与冠心病的关系研究[J].临床和实验医学杂志,2019,18:699-703. |
[6] | Schilcher I,Kern S,Hrzenjak A, et al.Impact of endothelial lipase on cholesterol efflux capacity of serum and high-density lipoprotein[J].Sci Rep,2017,7:12485.doi:10.1038/s41598-017-12882-7. |
[7] | Khetarpal SA,Vitali C,Levin MG, et al.Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins[J].PLoS Genet,2021,17:e1009802.doi:10.1371/journal.pgen.1009802. |
[8] | Wu L,Soundarapandian MM,Castoreno AB, et al.LDL-cholesterol reduction by angptl3 inhibition in mice is dependent on endothelial lipase[J].Circ Res,2020,127:1112-1114. |
[9] | Wang C,Nishijima K,Kitajima S, et al.Increased hepatic expression of endothelial lipase inhibits cholesterol diet-induced hypercholesterolemia and atherosclerosis in transgenic rabbits[J].Arterioscler Thromb Vasc Biol,2017,37:1282-1289. |
[10] | Wu YE,Ma L,Zhang H, et al.Significant association between the endothelial lipase gene 584C/T polymorphism and coronary artery disease risk[J].Biosci Rep,2020,40.doi:10.1042/BSR20200027. |
[11] | Schilcher I,Stadler JT,Lechleitner M, et al.Endothelial lipase modulates paraoxonase 1 content and arylesterase activity of HDL[J].Int J Mol Sci,2021,22.doi:10.3390/ijms22020719. |
[12] | 陈永宏,杨松,周建中.阿托伐他汀减轻肾性高血压大鼠血管重构[J].基础医学与临床,2010,30:383-388. |
[13] | Trimarco V,Izzo R,Morisco C, et al.High HDL(high-density lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients[J].Hypertension,2022,79:2355-2363. |
[14] | Yue X Wu M,Jiang H, et al.Endothelial lipase is upregulated by interleukin-6 partly via the p38 MAPK and p65 NF-κB signaling pathways[J].Mole Med Reports,2016,14: 1979-1985. |
[15] | Dalan AB,Toptaş B,Buǧra Z, et al.The effects of endothelial lipase gene (LIPG) variants on inflammation marker levels and atherosclerosis development[J].Mol Biol Rep,2013,40:5143-5149. |
[16] | Cadenas C,Vosbeck S,Edlund K, et al.LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer[J].Int J Cancer,2019,145:901-915. |
[17] | Nakajima H,Ishida T,Satomi-Kobayashi S, et al.Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake[J].Hypertension,2013,61:1002-1007. |
[18] | Schilcher I,Ledinski G,Radulović S, et al.Endothelial lipase increases antioxidative capacity of high-density lipoprotein[J].Biochim Biophys Acta Mol Cell Biol Lipids,2019,1864:1363-1374. |
[19] | Wan A,Rodrigues B.Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy[J].Cardiovasc Res,2016,111:172-183. |
[20] | Yan H,Niimi M,Wang C, et al.Endothelial lipase exerts its anti-atherogenic effect through increased catabolism of β-VLDLs[J].J Atheroscler Thromb,2021,28:157-168. |
[21] | Kobayashi J.Which is the Best predictor for the develop-ment of atherosclerosis among circulating lipoprotein lipase, hepatic lipase, and endothelial lipase?[J].J Atheroscler Thromb,2019,26:758-759. |
[22] | Yu X,Lu J,Li J, et al.Serum triglyceride lipase concentrations are independent risk factors for coronary artery disease and in-stent restenosis[J].J Atheroscler Thromb,2019,26:762-774. |
[23] | Tora G,Kim SH,Pi Z, et al.Identification of reversible small molecule inhibitors of endothelial lipase (EL) that demonstrate HDL-C increase in vivo[J].J Med Chem,2020,63:1660-1670. |
[24] | Johnson JA,Tora G,Pi Z, et al.Sulfonylated benzothia-zoles as inhibitors of endothelial lipase[J].ACS Med Chem Lett,2018,9:1263-1268. |
[25] | Ruff CT,Koren MJ,Grimsby J, et al.LEGACY: phase 2a trial to evaluate the safety, pharmacokinetics, and pharmacodynamic effects of the anti-EL(endothelial lipase) antibody MEDI5884 in patients with stable coronary artery disease[J].Arterioscler Thromb Vasc Biol,2021,41:3005-3014. |
[26] | Meng W,Adam LP,Behnia K, et al.Benzothiazole-based compounds as potent endothelial lipase inhibitors[J].Bioorg Med Chem Lett,2019,29:126673.doi:10.1016/j.bmcl.2019.126673. |
[1] | CHEN Linmu, HUANG Yunxiu. Chitosan oligosaccharides alleviates the formation of atherosclerotic plaque through up-regulating core-fucosylation of SRBI in mice [J]. Basic & Clinical Medicine, 2024, 44(4): 474-482. |
[2] | YU Hanqiao, LI Chao, YU Yubin, FENG Lina, SHENG Xiaosheng, YE Xiaoxia, WANG Linyan. Inhibition of triggering receptor expressed on myeloid cells-1(TREM-1) attenuates chronic intermittent hypoxia-induced atherosclerosis in mouse models [J]. Basic & Clinical Medicine, 2024, 44(3): 368-373. |
[3] | ZHANG Xiuli, HU Xiaogang, MO Jun, CHEN Ling. Guanxinning tablet alleviates carotid atherosclerotic plaque injury in rats [J]. Basic & Clinical Medicine, 2024, 44(2): 192-198. |
[4] | GUO Jianhong, WANG Yaling, CUI Wenguang. Research progress on the role of lipoprotein- associated phospholipase A2 in acute coronary syndrome [J]. Basic & Clinical Medicine, 2024, 44(1): 103-107. |
[5] | WU Guojia, ZHAI Shujie, SUN Xiao, HUANG Yiran, LI Yongmei, SUN Li. Progress of the effect of hydroxyacyl- coenzyme A dehydrogenase in cancer development and its mechanism [J]. Basic & Clinical Medicine, 2024, 44(1): 119-123. |
[6] | LI Xiang, LI Ye. Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2023, 43(8): 1294-1298. |
[7] | GAO Yuan, ZHENG Gang, QI Jing, ZHANG Feng. Progress of NLRP3 inflammasome in the pathogenesis of heart disease [J]. Basic & Clinical Medicine, 2023, 43(7): 1162-1166. |
[8] | WANG Xing, GUO Nan. Effect of obeticholic acid on glucolipid homeostasis in high-fat fed C57BL/6J mice [J]. Basic & Clinical Medicine, 2023, 43(5): 755-761. |
[9] | DU Fenghe, LIU Bao. Research progress on the mechanism of perivascular adipose tissue inflammation promoting atherosclerosis [J]. Basic & Clinical Medicine, 2023, 43(4): 685-689. |
[10] | ZHANG Yuanmou, HAN Kang, XIA Rui, SUN Wenjian, REN Xiaoying, WANG Yan. Effect of subclinical hypothyroidism on endocrine and metabolic characteristics of patients with polycystic ovary syndrome [J]. Basic & Clinical Medicine, 2023, 43(4): 641-646. |
[11] | LIU Yifei, WANG Xinyu, WANG Jiahui, DU Xiaobing, WANG Tu, ZHAO Juan. Urotensin Ⅱ receptor antagonist(urantide) alleviates renal injury in rats with atherosclerosis [J]. Basic & Clinical Medicine, 2023, 43(11): 1668-1672. |
[12] | WANG Xueran, TIAN Zongyuan, LIU Ruixia. Research progress on neuregulin 4 regulating lipid metabolism [J]. Basic & Clinical Medicine, 2023, 43(10): 1599-1603. |
[13] | ZENG Ying, FU Guili. Scutellaria Extract inhibits IL-22-induced hyperproliferation of human keratinocyte cell line HaCaT [J]. Basic & Clinical Medicine, 2023, 43(1): 123-129. |
[14] | LIU Zhen-zhu, LI Jing, HE Dan, QU Peng. Research progress of PI3K signaling pathway regulating the pathogenesis of atherosclerosis [J]. Basic & Clinical Medicine, 2022, 42(9): 1428-1432. |
[15] | ZHAO Mao-yu, LI You-mei, LIU Huan-yun, MAO Qi. Research progress of insulin resistance markers in atherogenesis [J]. Basic & Clinical Medicine, 2022, 42(8): 1302-1305. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 132
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 178
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||